{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:52:07Z","timestamp":1791409927364,"version":"4.3.3"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008856","name":"Zhejiang Provincial Health Commission","doi-asserted-by":"publisher","award":["2025KY099"],"award-info":[{"award-number":["2025KY099"]}],"id":[{"id":"10.13039\/501100008856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008990","name":"Science and Technology Department of Zhejiang Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008990","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007194","name":"Wenzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["Y20220206"],"award-info":[{"award-number":["Y20220206"]}],"id":[{"id":"10.13039\/501100007194","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110272","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T15:08:00Z","timestamp":1784992080000},"page":"110272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis, and evaluation of anti-solid-tumor activity of niclosamide-based STAT3\/HDAC dual-target inhibitors"],"prefix":"10.1016","volume":"181","author":[{"given":"Yuchen","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zipeng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouyang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faqing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuebao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.bioorg.2026.110272_bb0005","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.7150\/thno.26627","article-title":"Novel hybrid molecule overcomes the limited response of solid tumours to HDAC inhibitors via suppressing JAK1-STAT3-BCL2 signalling","volume":"8","author":"Guo","year":"2018","journal-title":"Theranostics"},{"issue":"7782","key":"10.1016\/j.bioorg.2026.110272_bb0010","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"A view on drug resistance in cancer","volume":"575","author":"Vasan","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110272_bb0015","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12964-024-01607-9","article-title":"Potentials and future perspectives of multi-target drugs in cancer treatment: the next generation anti-cancer agents","volume":"22","author":"Doostmohammadi","year":"2024","journal-title":"Cell Commun. Signal"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110272_bb0020","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s43856-025-01150-9","article-title":"Discovering anticancer drug target combinations via network-informed signaling-based approach","volume":"5","author":"Yavuz","year":"2025","journal-title":"Commun. Med."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110272_bb0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13045-024-01551-8","article-title":"Advances in targeting histone deacetylase for treatment of solid tumors","volume":"17","author":"Shi","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"15","key":"10.1016\/j.bioorg.2026.110272_bb0030","doi-asserted-by":"crossref","first-page":"19863","DOI":"10.18632\/oncotarget.7887","article-title":"Prognostic role of STAT3 in solid tumors: a systematic review and meta-analysis","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.bioorg.2026.110272_bb0035","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3390\/cancers16030492","article-title":"Exploring novel frontiers: leveraging STAT3 signaling for advanced cancer therapeutics","volume":"16","author":"Adesoye","year":"2024","journal-title":"Cancers"},{"issue":"Pt 3","key":"10.1016\/j.bioorg.2026.110272_bb0040","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1042\/bj20021321","article-title":"Histone deacetylases (HDACs): characterization of the classical HDAC family","volume":"370","author":"de Ruijter","year":"2003","journal-title":"Biochem. J."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110272_bb0045","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.molcel.2005.04.021","article-title":"HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor","volume":"18","author":"Kovacs","year":"2005","journal-title":"Mol. Cell"},{"issue":"5707","key":"10.1016\/j.bioorg.2026.110272_bb0050","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1105166","article-title":"Stat3 dimerization regulated by reversible acetylation of a single lysine residue","volume":"307","author":"Yuan","year":"2005","journal-title":"Science"},{"issue":"21","key":"10.1016\/j.bioorg.2026.110272_bb0055","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1182\/blood.V122.21.1032.1032","article-title":"Role of histone deacetylase 6 (HDAC6) in the modulation of STAT pathways and immune function of APCs","volume":"122","author":"Lienlaf","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bioorg.2026.110272_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117827","article-title":"Research progress of multi-target HDAC inhibitors blocking the BRD4-LIFR-JAK1-STAT3 signaling pathway in the treatment of cancer","volume":"110","author":"Jia","year":"2024","journal-title":"Bioorg. Med. Chem."},{"issue":"5\u20136","key":"10.1016\/j.bioorg.2026.110272_bb0065","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s10495-020-01607-3","article-title":"Citarinostat and Momelotinib co-target HDAC6 and JAK2\/STAT3 in lymphoid malignant cell lines: a potential new therapeutic combination","volume":"25","author":"Cosenza","year":"2020","journal-title":"Apoptosis"},{"issue":"10","key":"10.1016\/j.bioorg.2026.110272_bb0070","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010077","article-title":"HDAC inhibitor SAHA enhances antitumor immunity via the HDAC1\/JAK1\/FGL1 axis in lung adenocarcinoma","volume":"12","author":"Xu","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bioorg.2026.110272_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116765","article-title":"Isoalantolactone\/hydroxamic acid hybrids as potent dual STAT3\/HDAC inhibitors and self-assembled nanoparticles for cancer therapy","volume":"277","author":"Mo","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110272_bb0080","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.14593","article-title":"Discovering novel derivatives of STAT3 and HDAC inhibitors with anti-tumor activity","volume":"104","author":"Yang","year":"2024","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2026.110272_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112677","article-title":"Design and synthesis of novel flavone-based histone deacetylase inhibitors antagonizing activation of STAT3 in breast cancer","volume":"206","author":"Wei","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110272_bb0090","doi-asserted-by":"crossref","first-page":"7468","DOI":"10.1021\/acs.jmedchem.1c00136","article-title":"Discovery of STAT3 and histone deacetylase (HDAC) dual-pathway inhibitors for the treatment of solid Cancer","volume":"64","author":"Ren","year":"2021","journal-title":"J. Med. Chem."},{"issue":"16","key":"10.1016\/j.bioorg.2026.110272_bb0095","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.2174\/0929867329666220819093117","article-title":"Discovery of STAT3 inhibitors: recent advances and future perspectives","volume":"30","author":"Song","year":"2023","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110272_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105169","article-title":"Natural STAT3 inhibitors: a mini perspective","volume":"115","author":"Wang","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110272_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112122","article-title":"Allosteric inhibitors of the STAT3 signaling pathway","volume":"190","author":"Qin","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110272_bb0110","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1021\/ml100146z","article-title":"Identification of niclosamide as a new small-molecule inhibitor of the STAT3 signaling pathway","volume":"1","author":"Ren","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110272_bb0115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc3419","article-title":"WNT signalling pathways as therapeutic targets in cancer","volume":"13","author":"Anastas","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"21","key":"10.1016\/j.bioorg.2026.110272_bb0120","doi-asserted-by":"crossref","first-page":"17530","DOI":"10.1074\/jbc.M112.359638","article-title":"Structure\u2013activity analysis of niclosamide reveals a potential role for cytoplasmic pH in control of mammalian target of rapamycin complex 1 (mTORC1) signaling","volume":"287","author":"Fonseca","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110272_bb0125","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1158\/0008-5472.CAN-09-3950","article-title":"Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-\u03baB pathway and generation of reactive oxygen species","volume":"70","author":"Jin","year":"2010","journal-title":"Cancer Res."},{"issue":"24","key":"10.1016\/j.bioorg.2026.110272_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232416116","article-title":"Niclosamide as a promising therapeutic player in human cancer and other diseases","volume":"23","author":"Wang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110272_bb0135","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1042\/BCJ20190020","article-title":"New insights into Niclosamide action: autophagy activation in colorectal cancer","volume":"476","author":"Newton","year":"2019","journal-title":"Biochem. J."},{"key":"10.1016\/j.bioorg.2026.110272_bb0140","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejpb.2019.05.004","article-title":"Niclosamide repositioning for treating cancer: challenges and nano-based drug delivery opportunities","volume":"141","author":"Barbosa","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bioorg.2026.110272_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117527","article-title":"Pharmacological advances and therapeutic applications of niclosamide in cancer and other diseases","volume":"290","author":"Laila","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110272_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113362","article-title":"Discovery of N-substituted sulfamoylbenzamide derivatives as novel inhibitors of STAT3 signaling pathway based on Niclosamide","volume":"218","author":"Wang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110272_bb0155","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11262","article-title":"Insights into the activation mechanism of class I HDAC complexes by inositol phosphates","volume":"7","author":"Watson","year":"2016","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110272_bb0160","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ccell.2019.10.002","article-title":"A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo","volume":"36","author":"Bai","year":"2019","journal-title":"Cancer Cell"},{"issue":"16","key":"10.1016\/j.bioorg.2026.110272_bb0165","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110272_bb0170","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data","volume":"9","author":"Roe","year":"2013","journal-title":"J. Chem. Theory Comput."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110272_bb0175","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/ct300418h","article-title":"MMPBSA.Py: an efficient program for end-state free energy calculations","volume":"8","author":"Miller","year":"2012","journal-title":"J. Chem. Theory Comput."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826008084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826008084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:18:08Z","timestamp":1791407888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826008084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":35,"alternative-id":["S0045206826008084"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110272","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and evaluation of anti-solid-tumor activity of niclosamide-based STAT3\/HDAC dual-target inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110272","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110272"}}